Beactica: € 50k

Beactica is a specialist drug discovery company utilising its proprietary methodologies to evaluate the interaction of molecules in order to generate novel therapeutics. Beactica was granted € 50k from the SME Instrument HORIZON 2020, phase 1. GAEU helped structuring the project and highlight the parts essential in order for the commission to see the potential of the project, even though it was at a very early stage in its development, and very venturous.

MORE REFERENCES

FOLLOW US